Loading patent…
AssigneeKyungpook National University Industry-Academic Cooperation Foundation
InventorsMi-Kyung Park, Su-Hyeon Kim, Heejeong Lee
Estimating the term…
Provided are a bacteriophage KFS-ST3 having specific killing ability for Salmonella typhimurium and its derived biofilm, and a pharmaceutical composition for preventing or treating infectious diseases caused by Salmonella, including the bacteriophage. The bacteriophage KFS-ST3 of the present disclosure has specific killing ability for Salmonella, but does not kill beneficial bacteria and has excellent acid resistance and heat resistance, and thus may be not only used for the prevention or treatment of infectious diseases caused by Salmonella typhimurium and its derived biofilm, but also widely used in antibiotic compositions, feed additive compositions, disinfectants, or cleaning agents.
A method for treating an infectious disease caused by Salmonella Typhimurium, Salmonella Hartford, Salmonella Mission, Salmonella Senftenberg, or Salmonella Enteritidis, the method comprising administering an effective amount of a bacteriophage KFS-ST3 being deposited at the Korean Collection for Type Cultures (KCTC) under accession number KCTC 14872BP to a subject in need thereof.
Dependencies are inferred from the claim text.